Novo Nordisk A S
NVO- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000353278
No open-market purchases or sales by Novo Nordisk A S insiders were filed in the last 90 days; 1,355 institutions reported holding it in 13F filings for Q2 2026, worth $15.7B in total; superinvestors Markel Group and Maverick Capital hold it.
Other share classesNONOF
Q4 2021 vs. Q3 2021
How the institutions holding Novo Nordisk A S changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Of which not filed for Q4 2021 | Q4 2021 | Change |
|---|---|---|---|---|
| Holders | 806 | 11 | 887 | +92 |
| Shares | 132.2M | 115.0K | 131.8M | −247.1K (−0.2%) |
| Value | $12.7B | $11.0M | $14.7B | +$2.05B (+16.1%) |
11 institutions that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (150)
Institutions that held Novo Nordisk A S at the end of Q4 2021 but not at the end of Q3 2021.
Showing the largest 100 of 150 by value.
Sold out (58)
Institutions that held Novo Nordisk A S at the end of Q3 2021 and filed for Q4 2021 without it.
Not filed for Q4 2021 yet (11)
Institutions that held Novo Nordisk A S at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| BBVA USA | 46,433 | $4.46M |
| Cascadia Advisory Services, LLC | 26,731 | $2.57M |
| NorthCoast Asset Management LLC | 21,291 | $2.05M |
| Mid Atlantic Financial Management Inc | 8,863 | $851.0K |
| Security National Trust Co | 3,525 | $295.0K |
| Marshall Wace North America L.P. | 3,014 | $290.0K |
| Filbrandt Wealth Management, LLC | 2,695 | $259.0K |
| Heritage Wealth Management, LLC | 980 | $94.0K |
| Berman Capital Advisors, LLC | 940 | $89.0K |
| Wealth Quarterback LLC | 462 | $45.0K |
| Sonora Investment Management, LLC | 75 | $7.00K |